AntibodyCurated CoreFDAstaleUCBApproved
bimekizumab (Bimzelx, UCB4940, bimekizumab-bkzx)
Plaque psoriasis, psoriatic arthritis, axial spondyloarthritis, hidradenitis suppurativa · IL-17A / IL-17F
#IL-17AIL-17F#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 58Status Approved